FindTrial
Sign In

Patient-Specific Implant rehabilitation for Mucormycosis

Outcome assessment of indigenous designed Patient-Specific Implant with integrated Dental components for early rehabilitation of Oro Maxillary defect secondary to Post COVID-19 Rhino-Maxillary Mucormycosis, A Prospective Cohort Pilot Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/046999
Enrollment
24
Registered
2022-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B465- Mucormycosis, unspecified

Interventions

Intervention1: Patient-Specific Implant with integrated Dental components: i. Patient specific Implant (PSI) is fabricated as per the CASS Protocol (as mentioned in our plan of work section of this p

Sponsors

Indian Council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Patients with palatomaxillary Defect secondary to Post COVID-19 Rhino-Maxillary Mucormycosis ii. Loss of Dentate structure iii. History of surgical debridement for Post COVID-19 Rhino-Maxillary Mucormycosis

Exclusion criteria

Exclusion criteria: i. Presence of residual disease ii. Patient unwilling to consent for the study.

Design outcomes

Primary

MeasureTime frame
Maximum Bite ForceTimepoint: One month, 3 Month—

Secondary

MeasureTime frame
Implant StabilityTimepoint: Immediate, 1 Month, 3 month;Incidence of complications like peri-implant infectionTimepoint: 1 Month, 3 month;Quality of life assessment with WHOQOL-BREF scaleTimepoint: Preoperative, 1 Month, 3 month—

Countries

India

Contacts

Public ContactSanthosh Rao

All India Institute of Medical Sciences, Raipur

santhosh@aiimsraipur.edu.in9981525599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026